Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889388) titled 'RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Bionime Corporation
Condition:
Diabetes Mellitus, Type 1 Diabetes
Diabetes Mellitus, Type 2
Diabetes, Gestational
Intervention:
Device: RIGHTEST iFree 2 Continuous Glucose Monitoring System
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: June 9, 2026
Target Sample Size: 104
Countries of Recruitment:
Germany
To know more, visit https://clinical...